CSIMarket
 

Neurosense Therapeutics Ltd  (NASDAQ: NRSN)

Neurosense Therapeutics Ltd's

Competitiveness




 

NRSN Sales vs. its Competitors Q4 2025







Revenue Growth Comparisons




Net Income Comparison




<<  NRSN Stock Performance Comparisons


Neurosense Therapeutics Ltd's Comment on Competition and Industry Peers


The company operates in the biopharmaceutical industry, which is characterized by rapid technological change and significant competition. Potential competitors include large, experienced companies with substantial financial resources, research and development capabilities, manufacturing capacity, personnel, marketing expertise, brand recognition, and regulatory approval experience. These competitors may develop new drugs or seek approval for existing drugs targeting the same indications as the company. The company is aware of other entities developing potentially disease-modifying therapeutics for Amyotrophic Lateral Sclerosis (ALS).



*Market share is calculated based on total revenue.





Publicly Traded Peers of Neurosense Therapeutics Ltd



Sources: Neurosense Therapeutics Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Neurosense Therapeutics Ltd versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.